Michael Brian Bell Guardant Health, Inc. (GH) insider trading activity

Michael Brian Bell is Chief Financial Officer of Guardant Health, Inc.. Currently has a direct ownership of 29,665 shares of GH, which is worth approximately $2.8 Million. The most recent transaction as insider was on Dec 15, 2025, when has been sold 1,659 shares (Common Stock) at a price of $102.67 per share, resulting in proceeds of $170,329. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.7K

33.55% 3M change

15.48% 12M change

Total Value Held $2.8 Million

Michael Brian Bell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 15 2025	SELL Payment of exercise price or tax liability	$170,329 $102.67 p/Share	1,659 Reduced 5.3%	29,665 Common Stock
Dec 15 2025	BUY Exercise of conversion of derivative security	-	3,272 Added 9.46%	31,324 Common Stock
Dec 05 2025	SELL Open market or private sale	$8,357,648 $104.0 p/Share	80,362 Reduced 74.13%	28,052 Common Stock
Dec 05 2025	BUY Exercise of conversion of derivative security	$1,723,507 $30.62 p/Share	56,287 Added 34.18%	108,414 Common Stock
Oct 01 2025	SELL Payment of exercise price or tax liability	$482,091 $62.65 p/Share	7,695 Reduced 12.86%	52,127 Common Stock
Oct 01 2025	BUY Exercise of conversion of derivative security	-	15,181 Added 20.24%	59,822 Common Stock
Sep 15 2025	SELL Payment of exercise price or tax liability	$90,896 $54.79 p/Share	1,659 Reduced 3.58%	44,641 Common Stock

Sep 15 2025	BUY Exercise of conversion of derivative security	-	3,272 Added 6.6%	46,300 Common Stock
Jul 01 2025	SELL Payment of exercise price or tax liability	$53,600 $50.71 p/Share	1,057 Reduced 2.4%	43,028 Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	-	2,084 Added 4.51%	44,085 Common Stock
Jun 15 2025	SELL Payment of exercise price or tax liability	$81,772 $49.29 p/Share	1,659 Reduced 3.8%	42,001 Common Stock
Jun 15 2025	BUY Exercise of conversion of derivative security	-	3,272 Added 6.97%	43,660 Common Stock
Apr 01 2025	SELL Payment of exercise price or tax liability	$44,890 $42.47 p/Share	1,057 Reduced 2.55%	40,388 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	-	2,084 Added 4.79%	41,445 Common Stock
Mar 15 2025	SELL Payment of exercise price or tax liability	$71,154 $42.89 p/Share	1,659 Reduced 4.04%	39,361 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	3,272 Added 7.39%	41,020 Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$107,949 $42.55 p/Share	2,537 Reduced 6.3%	37,748 Common Stock
Mar 01 2025	BUY Exercise of conversion of derivative security	-	7,108 Added 15.0%	40,285 Common Stock
Feb 01 2025	SELL Payment of exercise price or tax liability	$110,919 $46.98 p/Share	2,361 Reduced 6.64%	33,177 Common Stock
Feb 01 2025	BUY Exercise of conversion of derivative security	-	6,617 Added 15.7%	35,538 Common Stock
Jan 15 2025	SELL Payment of exercise price or tax liability	$48,937 $37.5 p/Share	1,305 Reduced 4.32%	28,921 Common Stock
Jan 15 2025	BUY Exercise of conversion of derivative security	-	3,309 Added 9.87%	30,226 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$26,120 $30.55 p/Share	855 Reduced 3.08%	26,917 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	2,084 Added 6.98%	27,772 Common Stock
Dec 15 2024	SELL Payment of exercise price or tax liability	$57,666 $34.76 p/Share	1,659 Reduced 6.07%	25,688 Common Stock

Also insider at

CDNA

CareDx, Inc. Healthcare

Chief Financial Officer

MBB